FDA Cleared Products

Turn Therapeutics® has multiple, mass market-ready, proprietary assets incorporating our advanced delivery and healing technologies.

Hexagen® Wound Dressing

Acute and Chronic Wound Management

Hexagen® is non-irritating, non-cytotoxic, and non-sensitizing, as well as suitable for extended-wear. Hexagen Wound Dressing won’t dry up or macerate wounds like hydrogels. Hexagen Antimicrobial Wound Dressing is indicated for acute and chronic wounds.

XEAL Antimicrobial Dressing

Acute and Chronic Wound Management

XEAL Antimicrobial Dressings are single-use, sterile, antimicrobial gauze dressings impregnated with Hexagen®, Turn’s broad-spectrum, petrolatum-based, antimicrobial ointment. XEAL offers clinicians the same gentleness, feel and utility of traditional, petroleum-saturated gauze dressings, with added benefits such as antimicrobial protection.


Advanced Eczema Care

AtopX® employs our advanced healing technology to soothe the symptoms of atopic dermatitis at the source.


Our work—aimed at discovering cures—is a constant evolution and a challenge to the status quo. If modern medicine is the book, we will be the next breakthrough chapter.

– Bradley Burnam, CEO

Turn Therapeutics Reaches Licensing and Distribution Agreement with MIMEDX